-- ResMed (ASX:RMD) said that Chief Financial Officer Brett Sandercock plans to retire, effective May 4, according to a Friday statement by the company.
Aaron Bloomer will succeed Sandercock, who will remain an adviser to the chief executive through 2027, the company said.
Bloomer was CFO of Exact Sciences, which was recently acquired by New York Stock Exchange-listed Abbott.